A study conducted by Vella and colleagues demonstrated that the IGF2/insulin/IR-A/PI3K/MAPK axis contributes substantially to energetic metabolic phenotype of breast cancer MCF-7 cells by increasing glycolytic activity, mitochondrial functions and cell bioenergetics [88]. Here, IGF2 is linked to breast cancer.